v3.20.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2020
Dec. 31, 2019
Current assets:    
Cash and cash equivalents $ 33,410 $ 85,451
Marketable securities, current 82,816 39,633
Prepaid expenses 4,889 2,318
Grants revenue receivable 3,490 7,100
Accounts receivable, related party 301 408
In-process research and development - held for sale 4,500 4,500
Other current assets 249 489
Total current assets 129,655 139,899
Marketable securities, non-current 2,000 1,510
Operating lease right-of-use assets, non-current 11,589 9,959
Property and equipment, net 20,889 18,158
Other assets 5,244 4,676
Total assets 169,377 174,202
Current liabilities:    
Accounts payable 2,565 1,465
Accrued liabilities 13,231 14,544
Deferred revenue, current 12,496 8,511
Deferred revenue, current, related party 4,566 8,780
Other current liabilities, related party 5,498 0
Other current liabilities 2,041 2,501
Total current liabilities 40,397 35,801
Deferred revenue, long-term 7,785 18,944
Deferred revenue, long-term, related party 935 441
Long-term debt, net 14,822 2,940
Operating lease liabilities, non-current 12,828 11,682
Other liabilities, related party 6,711 0
Other liabilities 1,458 1,366
Total liabilities 84,936 71,174
Commitments and contingencies (Note 10) 0 0
Stockholders’ equity    
Preferred stock, $0.001 par value: Authorized: 2,000,000 shares at September 30, 2020 and December 31, 2019; issued and outstanding: 250 shares at September 30, 2020 and December 31, 2019 0 0
Common stock, $0.001 par value: Authorized: 150,000,000 shares at September 30, 2020 and December 31, 2019; issued and outstanding: 49,963,732 shares at September 30, 2020 and 45,589,157 shares at December 31, 2019 50 46
Additional paid-in capital 324,914 267,089
Accumulated other comprehensive income 73 18
Accumulated deficit (240,596) (164,125)
Total stockholders’ equity 84,441 103,028
Total liabilities and stockholders’ equity $ 169,377 $ 174,202

Source